Staged, office-based treatment of debilitating, limb-threatening hand arteriovenous malformations with a Venaseal cyanoacrylate-based embolization strategy

采用基于Venaseal氰基丙烯酸酯的栓塞策略,分阶段、门诊治疗致残性、危及肢体的手部动静脉畸形。

阅读:1

Abstract

The aim of this study was to demonstrate a novel, office-based treatment of life-threatening hand arteriovenous malformations (AVMs) via Venaseal cyanoacrylate embolization. Two adult male patients with debilitating Yakes II hand AVMs underwent staged, transarterial, and direct-stick Venaseal embolization in an office-based setting over a period of 12 (7 sessions) and 8 (4 sessions) months. Technical success was 100% with no complications. Clinical success was achieved with ulcer and cardiopulmonary overload alleviation, nonrestricted restoration of hand function, and reduction in lesion volume confirmed by Doppler flow rate measurements. Interim results after 9-month follow-up revealed sustained relief with no recurrence clinically or ultrasonographically. We present a novel, office-based approach to safe, effective, and durable embolization of advanced hand AVMs using Venaseal cyanoacrylate and have found AVM nidal flow rate measurements on Doppler useful for objective assessment of AVM hemodynamics and response to treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。